Sugen takes second shot at UK flotation
Thursday 15 May 1997
The California-based Sugen, which already has a quote on the US's Nasdaq exchange, deferred plans to float last year following a slump in UK biotechnology prices. However, recently revived confidence in the sector could herald a stream of biotech flotations over the next two years.
One flotation in the pipeline is Biovector Therapeutics, the French drug delivery company. It said yesterday it hoped to raise around $50m in a flotation in the UK or on Europe's Easdaq market early next year, a move that would value the group at around $150m. Biovector, which this month announced a tie-up with US group Biochem Pharma to develop an influenza vaccine, has appointed Dresdner Kleinwort Benson as advisers.
Sugen, which specialises in developing cancer drugs, does not plan to raise new money when it launches in the UK. Speaking at a biotechnology conference hosted by Rothschild in London yesterday, Stephen Evans-Freke, Sugen's founder and chief executive, said: "Our share price in the US does not make fund-raising sensible at this point.
"We want to reach a broader audience of European investors. We know many who are keen to take a position, but they are restricted at the moment."
Mr Evans-Freke said Sugen now had a lower risk profile after successfully taking its most advanced drug for brain cancer into late-stage clinical trials. "The time is right for us in the UK," he said.
British-born Mr Evans-Freke, who owns 5 per cent of the company, moved to the US where he sold his first biotechnology start-up, Selectide, to the Marion Merrill Dow drug giant, now part of Hoechst, for $58m in 1994. He founded Sugen in 1990, floating it on Nasdaq four years later.
After Zeneca, which invested $33m for its 20 per cent share, Sugen's second-largest shareholder is Rothschild's venture capital arm, Biotechnology Investments, which owns 6 per cent. Jeremy Curnock Cook, a director of Biotechnology Investments, took a seat on Sugen's board in January.
- 1 Keira Knightley topless: Usually conservative actress does own take on #Freethenipple campaign for Interview Magazine
- 2 Joan Rivers: 'Palestinians deserve to be dead'
- 3 Lady al-Qa’ida: On the trail of Dr Aafia Siddiqui, the world’s most wanted prisoner
- 4 A teacher speaks out: 'I'm effectively being forced out of a career that I wanted to love'
- 5 It's not just the savagery of Isis that is shocking – its weaponry is too
YouTube video posted by Isis militants shows 'execution of 250 Syrian soldiers'
Keira Knightley topless: Usually conservative actress does own take on #Freethenipple campaign for Interview Magazine
Joan Rivers: 'Palestinians deserve to be dead'
Sir Paul McCartney makes his stance on Scottish independence known
PM sets out tough new anti-terror measures in response to heightened threat
Robin Williams Emmys tribute led by Billy Crystal criticised for including 'racist' joke about Muslim woman
The Rotherham child abuse scandal is a tale of apologists, misogyny and double standards
What do immigrants really think of Britain? Polish immigrant's Reddit post goes viral
Scottish independence TV debate: Pumped-up Alex Salmond bounces back in bruising second round against Alistair Darling
Do you realise just how foolish the UK looks?
With Douglas Carswell joining Ukip, my party has taken another giant step forward
- < Previous
- Next >
iJobs Money & Business
Highly Attractive Salary: Austen Lloyd: BRISTOL - This is a very unusual law c...
£35000 per annum: Harrington Starr: Network Engineer (CCNP, CCNA, Linux, OSPF,...
£50000 per annum: Harrington Starr: DevOps Engineer (Systems Administration, L...
£60000 - £70000 per annum: Harrington Starr: A prestigious leading professiona...